Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point increase » unit increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point increase » unit increase (Expand Search)
-
2181
-
2182
-
2183
-
2184
-
2185
-
2186
-
2187
-
2188
-
2189
-
2190
-
2191
-
2192
-
2193
Column charts of WiAUC in therapy and control group at baseline and follow-up.
Published 2025Subjects: -
2194
-
2195
-
2196
-
2197
Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2198
Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2199
Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”
-
2200